Although the Oncotype DX test has already been approved for use, research involving the test is ongoing. The Oncotype DX test plays a key role in a current clinical trial, the Trial Assigning IndividuaLized Options for Treatment (Rx), known as TAILORx. Participants will be divided into different treatment groups depending on their Recurrence Score&...